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Abstract
Background: Alcohol consumption is one of the major risk factors for colorectal cancer. However, the mechanism
involved in this effect of alcohol is unknown.
Methods: We evaluated the effect of chronic ethanol feeding on azoxymethane and dextran sulfate sodium
(AOM/DSS)-induced carcinogenesis in mouse colon. Inflammation in colonic mucosa was assessed at a precancerous
stage by evaluating mucosal infiltration of neutrophils and macrophages, and analysis of cytokine and chemokine gene
expression.
Results: Chronic ethanol feeding significantly increased the number and size of polyps in colon of AOM/DSS treated
mice. Confocal microscopic and immunoblot analyses showed a significant elevation of phospho-Smad, VEGF and
HIF1α in the colonic mucosa. RT-PCR analysis at a precancerous stage indicated that ethanol significantly increases the
expression of cytokines IL-1α, IL-6 and TNFα, and the chemokines CCL5/RANTES, CXCL9/MIG and CXCL10/IP-10 in the
colonic mucosa of AOM/DSS treated mice. Confocal microscopy showed that ethanol feeding induces a dramatic
elevation of myeloperoxidase, Gr1 and CD68-positive cells in the colonic mucosa of AOM/DSS-treated mice. Ethanol
feeding enhanced AOM/DSS-induced suppression of tight junction protein expression and elevated cell proliferation
marker, Ki-67 in the colonic epithelium.
Conclusion: This study demonstrates that chronic ethanol feeding promotes colonic tumorigenesis potentially by
enhancing inflammation and elevation of proinflammatory cytokines and chemokines.
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Background
Alcohol is identified by World Health Organization as
one of the top ten risk factors for worldwide burden of
disease [1]. A significant body of evidence indicates that
chronic alcohol consumption increases the risk for can-
cer of many organs, including the respiratory tract,
gastrointestinal tract, liver and breast [2–6]. Inter-
national Agency for Research on Cancer concluded that
alcohol is carcinogenic to humans at Group I category,
the highest causality classification.
Colorectal cancer is the second common cause of death
among adult cancer patients. Alcohol consumption is one
of the major risk factors for colorectal cancer [7–9]. Al-
though few animal studies failed to show a significant ef-
fect of ethanol on dimethylhydrazine (DMH)-induced
colonic tumorigenesis [10–12], many studies showed that
alcohol administration causes a significant increase in the
incidence and tumor growth induced by DMH or methyl
azoxymethanol (MAM) in rats [13–16]. Ethanol however
was found to decrease the incidence of azoxymethane
(AOM)-induced tumorigenesis in rats [17, 18]. Interest-
ingly, tumorigenesis models in all these studies used the* Correspondence: rrao2@uthsc.edu
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carcinogens to induce carcinogenesis without involving
inflammation.
Although several mechanisms have been proposed [19],
inflammation appears to be one of the major mechanisms
associated with the development of colon cancer [20, 21].
An association between colorectal cancer and ulcerative
colitis has been well established [22]. Histopathologic ana-
lysis indicates a role for inflammation in colon carcino-
genesis in ulcerative colitis patients, which is confirmed in
animal models of ulcerative colitis [21]. Ulcerative colitis
patients complain of worsening gastrointestinal symptoms
with alcohol consumption [23]. Alcohol consumption ac-
tivates mast cells in response to oncogenic signals [24],
suggesting that alcohol may have a significant impact on
the intestinal mucosal inflammation.
In this study, we evaluated the effect of chronic etha-
nol feeding on AOM and dextran sulfate sodium (DSS)-
induced tumorigenesis in mouse colon. Additionally, we
analyzed the effect of ethanol feeding on colonic muco-
sal inflammation and expression of cytokines and che-
mokines at a precancerous stage.
Methods
Chemicals
DSS was purchased from Thermo Fisher Scientific (Tustin,
CA) and AOM was purchased from Sigma-Aldrich (St.
Louis, MO). Hoechst 33342 dye was purchased from
Life technologies (Grand Island, NY). Precast, SDS-
polyacrylamide gels were purchased from Invitrogen
(Carlsbad, CA). All other chemicals were either from
Sigma-Aldrich or Fisher Scientific.
Antibodies
Anti-phospho Smad2 (pSmad; Cat#AB3849), anti-Ki-67
(Cat# AB9260), HRP-conjugated anti-rabbit IgG (Cat#
12–348), and anti-vascular endothelial growth factor
(VEGF; Cat# 05–443) were purchased from Millipore
(Billerica, MA). Anti-caspase-3 antibody (Cat# 9661)
was from Cell Signaling Technology (Danvers, MA).
Anti-CD68 antibody (Cat# 6A324) was purchased from
Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Anti-
hypoxia-inducible factor 1-alpha (HIF-1α; Cat#NB-100-
449) was purchased from Novus Biologicals (Littleton, CO).
Anti-occludin (Cat#331500) and anti-ZO-1 (Cat#617300)
antibodies were purchased from Invitrogen. Anti-
granulocyte receptor-1 (Gr1; Cat# MBS520313) was from
MyBioSource (San Diego, CA). Horseradish peroxidase
(HRP)-conjugated anti-mouse IgG (Cat# A4116), Cy3-
conjugated anti-rabbit IgG (Cat# C2306) and anti-β-actin
(Cat# A5441) antibodies were purchased from Sigma-
Aldrich. Anti-myeloperoxidase (MPO) (Cat#DOM00001G),
anti-claudin-3 (Cldn3; Cat# 341700), AlexaFlour 488-
conjugated anti-mouse IgG (Cat# A11029), AlexaFluor
488-phalloidin (Cat# A12379), AlexaFluor 546-phalloidin
(Cat# A22283), and anti-TNFα (Cat# AMC3012) antibodies
were purchased from Thermo Fisher Scientific.
Animals and diets
Female C57BL/6 mice (12–14 weeks, Harlan Laboratories,
Houston, TX) were used for all experiments. All animal
experiments were performed according to the protocol
approved by the University of Tennessee Health Science
Center-Institutional Animal Care and Use Committee.
Animals were housed in institutional animal care facility
with 12-h light and dark cycles and had free access to
regular laboratory chow and water until the start of exper-
iments. Lieber DeCarli diet (Dyet # 710260) was pur-
chased from Dyets Inc. (Bethlehem, PA) and maltodextrin
was from Bioserv (Flemington, NJ).
Colonic tumorigenesis
Mice received one time injection of AOM (10 mg/kg
BW) at the beginning of experiment. Five days after
AOM injection, recurrent colitis was induced by admin-
istering DSS (3 %w/v) in drinking water; three 5-day
courses with 15-day intervals. Tumorigenesis was ob-
served at 30 days after the third DSS cycle. During the
15-day intervals and during the 30 days after 3rd DSS
cycle, animals were fed Lieber-DeCarli liquid diet with
or without 4 % ethanol (EtOH); non-EtOH group were
pair fed isocaloric diet (adjusted with maltodextrin). For
tumorigenesis studies (80 days total) 7 and 9 mice were
used for AOM+DSS and AOM+DSS + EtOH, respect-
ively. One mouse in AOM+DSS group and 2 mice in
AOM+DSS + EtOH group died before the end of ex-
periment. For precancerous studies (44 days period), 7
mice each were used for AOM+DSS and AOM+DSS
+ EtOH groups and no mice died in these experiments.
Again 4 mice were used for control groups in all experi-
ments. Colons were evaluated for polyp number and
size. Cryosections were examined for carcinogenesis
markers, pSmad, VEGF and HIF-1α.
Quantitative RT-PCR
Total RNA (1.5 μg) was used for generation of cDNAs
using the ThermoScript RT-PCR system for first strand
synthesis (Invitrogen). Quantitative PCR (qPCR) reac-
tions were performed using cDNA mix (cDNA corre-
sponding to 35 ng RNA) with 300 nmoles of primers in
a final volume of 25 μl of 2× concentrated RT2 Real-
Time SYBR Green/ROX master mix (Qiagen) in an
Applied Biosystems 7300 Real-Time PCR instrument
(Norwalk, CT, USA). The cycle parameters were: 50 °C
for 2 min, one denaturation step at 95 °C for 10 min
and 40 cycles of denaturation at 95 °C for 10s followed
by annealing and elongation at 60 °C. Relative gene ex-
pression of each transcript was normalized to GAPDH
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using the ΔΔCt method. Sequences of primers used for
qPCR are provided in Table 1.
Immunofluorescence microscopy
Colons were examined for inflammatory markers MPO
(neutrophil), Gr1 (neutrophil) and CD68 (macrophage)
by confocal microscopy at a precancerous stage and
tumorigenesis markers were examined when polyps were
fully developed. Cryo-sections of distal colon (10 μm
thickness) were fixed in acetone:methanol mixture (1:1)
at 20 °C for 2 min and rehydrated in phosphate buffered
saline (PBS). Sections were permeabilized with 0.2 %
Triton X-100 in PBS for 15 min and blocked in 4 %
non-fat milk in TBST (20 mM Tris, pH 7.2 and 150 mM
NaCl). It was then incubated for 1 h with primary anti-
bodies (rabbit polyclonal anti-pSmad, VEGF, Ki67, ZO1,
Cldn3 and HIF-1α or mouse monoclonal anti-occludin;
all at 1:100 dilution) followed by incubation with sec-
ondary antibodies (Cy3-conjugated anti-rabbit IgG anti-
bodies at 1:100 dilution; Molecular Probes, Eugene,
OR) and co-stained with AlexaFlour 488-conjugated
phalloidin and Hoechst 33342 for 1 h. The fluorescence
was examined by using a confocal microscope (Zeiss
710) and images from x-y sections (1 μm) were col-
lected using Zen software. Images were stacked using
the Image J software (NIH, Bethesda, MD) and proc-
essed by Adobe Photoshop (Adobe Systems Inc., San
Jose, CA).
Preparation of mucosal extract
Mucosal scrapping from distal colon was incubated on
ice for 15 min with lysis buffer-CS (Tris buffer contain-
ing 1 % Triton-X100, 2 μg/ml leupeptin, 10 μg/ml apro-
tinin, 10 μg/ml bestatin, 10 μg/ml pepstatin-A, 10 μl/ml
of protease inhibitor cocktail, 1 mM sodium orthovana-
date and 1 mM phenylmethyl sulfonylfluoride. Mucosal
lysates were centrifuged at 15,600 × g for 4 min at 4 °C
to collect total fraction. Protein content was measured
by BCA method (Pierce Biotechnology, Rockford, IL).
Total fraction was mixed with equal volume of Laemm-
li’s sample buffer (2× concentrated), heated at 100 °C
for 5 min, and 40 μg proteins from each sample was
used for immunoblot analysis.
Immunoblot analysis
Total mucosal fractions were separated by SDS-
polyacrylamide gel (7 %) electrophoresis and transferred
to PVDF membranes. Membranes were immunoblotted
for different proteins using specific antibodies for anti-
occludin (1:250 dilution), pSmad (1:1000 dilution) and
VEGF with β-actin (1:5000 dilution) as house keeping
protein in combination with HRP-conjugated anti-
mouse IgG or anti-rabbit IgG secondary antibodies
(1:2000 dilution). The blots were developed using ECL
chemiluminescence method (Pierce, Rockford, IL) and
quantitated by densitometry using Image J software. The
density for each band was normalized to density of cor-
responding actin band.
Statistical analyses
All data are expressed as Mean ± SEM. The differences
among multiple groups were first analyzed by ANOVA
(Prism 6.0). When a statistical significance was detected,
Tukey’s t test was used to determine the statistical sig-
nificance between multiple testing groups and the corre-
sponding control. Statistical significance was established
at 95 %.
Results
Ethanol feeding promotes AOM/DSS-induced colonic
tumorigenesis
Ethanol was fed during the post colitis recovery period of
AOM/DSS-induced colonic tumorigenesis, which is likely
to have an influence on post colitis healing (Fig. 1a). Etha-
nol feeding did not cause a significant alteration of body
weight during the AOM/DSS-induced tumorigenesis
(Fig. 1b). As shown before, AOM/DSS treatment resulted
in the development of tumors in the distal colon, which
was significantly elevated by ethanol feeding. Total number
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of tumors was elevated nearly 4-fold by ethanol feeding
(Fig. 1c). Interestingly, in the absence of ethanol, diameter
of all tumors was less than 3 mm. On the other hand,
diameter of more than half of the tumors in ethanol fed
mice was 3 mm or greater (Fig. 1c). Representative photo-
graphs of colons from mice in different groups are pre-
sented in Fig. 2.
Ethanol feeding enhances tumorigenic markers in the colon
We analyzed the levels of the tumor markers, VEGF,
pSmad and HIF1α, by immunofluorescence microscopic
method. Images from the tumor tissue as well as the
non-tumor hypertrophic colonic mucosa in the same
colon were separately examined. Low levels of VEGF
stain was present in the colon of ethanol fed-AOM/DSS
Fig. 1 Ethanol feeding increases AOM/DSS-induced tumorigenesis in mouse colon. a The scheme shows one time administration of azoxymethane
(AOM) followed by three course of DSS (dextran sodium sulfate)-induced colitis and separated by 15-day recovery periods. Colon was examined 30 days
after the third course of DSS colitis. During all recovery periods, animals were fed liquid diet with or without 4 % ethanol (EtOH) or isocaloric maltodextrin.
b Body weights were recorded twice a week. Values represent the mean of 7–9 samples per group. c The number of tumors per colon was counted and
the tumor size evaluated by measuring the diameter in AOM/DSS-treated mice with (EF) or without (PF) EtOH feeding. Values for total tumors per colon
and tumors of 3 mm or greater diameter are mean ± SEM (n= 6 for PF and 7 for EF). Asterisks indicate the values that are significantly different (p < 0.05)
from corresponding values for PF group
Fig. 2 Ethanol feeding increases AOM/DSS-induced tumorigenesis in mouse colon. Photographs of colons from 3 animals per group are presented
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treated mice, but relatively high levels of VEGF stain
was present in the non tumor hypertrophic colonic mu-
cosa of AOM/DSS treated mice with or without ethanol
feeding (Fig. 3a). In the hypertrophic colonic mucosa,
VEGF was localized predominantly in the lamina propria
region. High level of VEGF was also detected in the
tumor tissue, where it was distributed predominantly in
the sub epithelial connective tissue regions. The stain for
pSmad was very low in hypertrophic colonic mucosa in
the ethanol fed or AOM/DSS treated mice, but the stain
was dramatically higher in colon of ethanol fed-AOM/
DSS treated mice (Fig. 3b). Stain for pSmad was also lo-
calized predominantly in the lamina propria. Higher
levels of stain for pSmad were detected in the tumor tis-
sues in AOM/DSS treated mice with or without ethanol
feeding. HIF1α level was low in the colon of ethanol fed
control mice, and AOM/DSS treatment had a very little
effect on HIF1α level in the hypertrophic colon (Fig. 3c).
Ethanol feeding dramatically elevated HIF1α stain in the
hypertrophic colon of AOM/DSS treated mice, which
once again was localized predominantly in lamina pro-
pria. Higher level of stain for HIF1α was present in the
tumor tissues, but ethanol appeared to reduce this stain.
Immunoblot analysis of hypertrophic colonic mucosal
extracts showed low levels of pSmad in pair fed and etha-
nol fed controls, which was significantly elevated in
AOM/DSS treated mice (Fig. 4a). Ethanol feeding further
elevated pSmad in the colon of AOM/DSS treated mice
(Fig. 4a and b). Similarly, significant level of VEGF was
present in the colon of ethanol control mice. The level of
VEGF was unaffected by AOM/DSS treatment, but etha-
nol feeding significantly elevated VEGF stain in the colon
of AOM/DSS treated mice. Enlarging images for HIF1α in
the crypt region of hypertrophic colon from AOM/DSS
and ethanol fed-AOM/DSS treated mice show that etha-
nol feeding enhanced nuclear translocation of HIF1α
(Fig. 4c).
Ethanol causes sustained inflammation in the colon of
AOM/DSS-treated mice
At 2 weeks after the second course of DSS colitis (Fig. 1a),
we examined colonic mucosa for inflammation by staining
colonic sections for MPO, Gr1 (neutrophil marker) or
CD68 (macrophage marker) by immunofluorescence
staining method. Colon from ethanol control mice and
AOM/DSS treated mice showed no stain for MPO-
positive cells (Fig. 5a). But, there were numerous MPO-
positive cells present in the colonic mucosa of ethanol
fed-AOM/DSS treated mice. Similarly, Gr1-positive cells
were not detectable in the colon of ethanol or AOM/DSS
treated mice (Fig. 5b), but numerous Gr1-positive cells
were present in the colonic mucosa of ethanol fed-AOM/
DSS treated mice. CD68-positive cells were detected in
the colonic mucosa of ethanol fed and AOM/DSS treated
mice (Fig. 5c). CD68-positive cells appear to be relatively
high in the colon of ethanol fed-AOM/DSS treated mice.
Ethanol feeding elevates cytokine and chemokine gene
expression in colonic mucosa of AOM/DSS treated mice
To determine the effect of ethanol feeding on post colitis
recovery, we measured mRNA for cytokines and chemo-
kines at a precancerous stage, that is 2 weeks after the sec-
ond course of DSS colitis (Fig. 1a). The levels of mRNA
for IL-6 in colonic mucosa of ethanol control and AOM/
DSS treated mice were not different from those in control
mice (Fig. 6a). IL-6 mRNA level was nearly 4-fold higher
in colonic mucosa of ethanol fed-AOM/DSS treated mice.
IL-1α mRNA levels were similar in the colon of pair fed
Fig. 3 Chronic ethanol feeding enhances tumorigenesis markers during AOM/DSS-induced tumorigenesis. AOM/DSS-induced colonic
tumorigenesis was induced with (EF) or without (PF) 4 % ethanol feeding as described in Methods section. Cryosections of distal colon were
stained for VEGF (a) pSmad (b), or HIF1α (c), and co-stained for F-actin and nucleus. Images presented are representative of n of 5 for each group
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Fig. 4 Ethanol elevates tumorigenic markers and nuclear localization of HIF1α in colonic crypts during AOM/DSS-induced tumorigenesis: AOM/
DSS-induced colonic tumorigenesis was induced with or without 4 % ethanol feeding as described in Methods section. a & b Colonic mucosal
extracts were immunoblotted for pSmad and VEGF (a), and the band density evaluated using Image J software (b). Values are mean ± SE (n = 3).
Asterisks indicate the values that are significantly different (p < 0.05) from corresponding values for AOM/DSS group. c Cryosections of colon were
stained for HIF1α (red) and nucleus (blue). Sections of the images from Fig. 2c are enlarged to show the detailed localization of HIF1α in the
nucleus. While arrows indicate nuclear co-localization of HIF1α
Fig. 5 Ethanol elevates inflammatory cells in colonic mucosa of AOM/DSS-treated mice: AOM/DSS-induced colonic tumorigenesis was induced with (EF)
or without (PF) 4 % ethanol feeding as described in Methods section. At the pre-cancerous stage (Day 44; 2 week after second course od DSS colitis)
cryosections of distal colon were stained for myeloperoxidase (MPO) (a), Gr1 (b) and CD68 (c) and co-stained for F-actin and nucleus. Images presented
are representative of n of 5 for each group
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control and ethanol fed mice (Fig. 6b). But, it was about 2-
fold higher in the colon of AOM/DSS treated mice and
nearly 5-fold higher in the colon of ethanol fed-AOM/
DSS treated mice. Similar to IL-6 mRNA, the levels of
mRNA for TNFα in the colon of pair fed control, ethanol
fed and AOM/DSS treated mice were not significantly dif-
ferent from each other (Fig. 6c). But, it was 4-5-fold higher
in the colon of ethanol fed-AOM/DSS treated mice
(Fig. 6c). The levels of mRNA for IL-1β were not different
in different groups (data not presented).
CCL5/RANTES mRNA level was significantly higher
in the colon of ethanol fed mice compared to that in
pair fed mice (Fig. 6d). But, it was nearly 4-fold higher in
the colon of ethanol fed-AOM/DSS treated mice. The
levels of mRNA for CXCL9/MIG and CXCL10/IP-10
were not significantly different in the colons of pair fed
control, ethanol control and AOM/DSS treated mice
(Fig. 6e and f). But, they were 5-8-fold higher in the
colon of ethanol fed-AOM/DSS treated mice.
Cytokines mRNA levels were also measured in the
ileum. Unlike in colon, the mRNA for IL-1α (Fig. 7a), IL-6
(Fig. 7b) and TNFα (Fig. 7c) in ileum were significantly
higher in ethanol fed mice compared to that in pair fed
control mice. IL-1α, IL-6 and TNFα mRNA levels were
significantly higher in the ileum of AOM/DSS-treated
mice. In AOM/DSS treated mice, ethanol feeding reduced
the mRNA for IL-1α and increased TNFα mRNA, but had
no effect on IL-6 mRNA levels. CCL5/RANTES (Fig. 7d),
CXCL9/MIG (Fig. 7e) and CXCL10/IP-10 (Fig. 7f) mRNA
levels in the ileum were slightly, but significantly higher in
AOM/DSS-treated mice, but they were several folds
higher in the ethanol fed-AOM/DSS treated mice.
Ethanol promotes AOM/DSS-induced suppression of tight
junction protein gene expression and elevation of cell
proliferation marker
Occludin (Fig. 8a), ZO-1 (Fig. 8b) and Cldn3 (Fig. 8c)
mRNA levels were dramatically low in AOM/DSS-
treated mouse colon, and ethanol feeding further sup-
pressed the mRNA for these proteins. Ethanol by itself
did not affect occludin mRNA, but almost completely
depleted ZO-1 and Cldn3 mRNA. Immunofluorescence
staining showed only a slight effect on occludin and ZO-
1 protein levels (Fig. 8d). AOM/DSS treatment caused a
more severe depletion of occludin and ZO-1, which was
further suppressed by ethanol feeding.
The number of Ki-67-positive cells in the colon was
not different in ethanol and pair fed mice with or with-
out AOM/DSS treatment (Fig. 9a). However, the fluores-
cence intensity in positive cells was significantly high in
the colon of AOM/DSS treated mice, which was further
elevated by ethanol feeding (Fig. 9b). Ethanol, in the ab-
sence of AOM/DSS, also showed a slight by significant
increase in Ki-67 levels. Staining for caspase-3 showed
Fig. 6 Chronic ethanol feeding promotes cytokine and chemokine gene expression in AOM/DSS-induced colonic tumorigenesis. AOM/DSS-induced
colonic tumorigenesis was induced with (EF) or without (PF) 4 % ethanol feeding as described in Methods section. At the pre-cancerous stage (Day 44;
2 week after second course od DSS colitis), qRT-PCR analysis performed in RNA from distal colonic mucosa for IL-6 (a), IL-1α (b), TNFα (c), CCL5/RANTES
(d), CXCL9/MIG (e) and CXCL10/IP-10 (f). Values are mean ± SE (n = 7). Asterisks indicate the values that are significantly (p < 0.05) different from
corresponding PF values. Hash tag symbol indicates the value that is significantly (p < 0.05) different from corresponding “Control” value
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Fig. 7 Chronic ethanol feeding modulates cytokines gene expression in the ileum of AOM/DSS treated mice. AOM/DSS-induced colonic tumorigenesis
was induced with (EF) or without (PF) 4 % ethanol feeding as described in Methods section. At the pre-cancerous stage (Day 44; 2 week after second
course of DSS colitis), qRT-PCR analysis performed in RNA from ileal mucosa for IL-6 (a left), IL-1α (b left), TNFα (c left), CCL5/RANTES (a right), CXCL9/MIG
(b right) and CXCL10/IP-10 (c right). Values are mean ± SE (n= 4). Asterisks indicate the values that are significantly (p< 0.05) different from corresponding
PF values. Hash tag symbols indicate the values that are significantly (p < 0.05) different from corresponding “Control” values
Fig. 8 Chronic ethanol feeding modulates gene expression of tight junction proteins in the colon of AOM/DSS treated mice. AOM/DSS-induced colonic
tumorigenesis was induced with (EF) or without (PF) 4 % ethanol feeding as described in Methods section. a-c At the pre-cancerous stage (Day 44; 2 week
after second course of DSS colitis), qRT-PCR analysis performed in RNA from distal colonic mucosa for occludin (a), ZO-1 (b) and claudin-3 (c). Values are
mean ± SEM (n= 4). Asterisks indicate the values that are significantly (p< 0.05) different from corresponding PF values. Hash tag symbols indicate the values
that are significantly (p < 0.05) different from corresponding “Control” values. d Cryosections of colon were stained for occludin (green) and ZO-1 (red)
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no positive cells in the colon of all groups, except for de-
tection of few likely hematopoietic cells in the lamina
propria of colon from AOM/DSS treated mice (Fig. 9c).
Discussion
Alcohol consumption is one of the major risk factors for
colorectal cancer [7–9]. Many experimental studies
showed that ethanol feeding significantly increases the
incidence of DMH or MAM-induced tumor growth in
rat colon [13–16], and promotes tumor invasion in
C57BL/6-APCMin mice [24]. However, ethanol was found
to decrease the incidence of AOM-induced tumorigenesis
in rats [17, 18]. A significant body of evidence indicates that
inflammation is an important second hit in the develop-
ment of most types of cancer including colon cancer [25].
Therefore, in this study we used AOM/DSS-induced colon
carcinogenesis model that combines the effects of a car-
cinogen and colitis to evaluate the effect of ethanol con-
sumption on colon cancer. Results of this study explicitly
provide robust evidence to ethanol-mediated promotion of
AOM-induced tumorigenesis in mouse colon potentially by
enhancing mucosal inflammation.
Our study shows that chronic ethanol feeding causes a
dramatic increase in the number and size of tumors in
AOM/DSS treated mice. AOM and DSS treatments have
previously been shown to induce tumorigenesis in the dis-
tal colon [26–28]. The present study, for the first time,
demonstrates that chronic ethanol feeding enhances
AOM/DSS-induced tumorigenesis in mouse colon. Al-
though previous studies have shown that ethanol increases
the incidence of colonic tumorigenesis induced by differ-
ent carcinogens, the ethanol effect on-induced tumorigen-
esis is not known. Previous studies showed that high dose
of AOM administration induces colonic tumorigenesis in
Fischer 344 rats with 50 % prevalence [17, 18], but ethanol
feeding (11–33 % calories) resulted in a dose-dependent
reduction of prevalence of tumorigenesis. This is in con-
trast to the results of our present study. The difference
Fig. 9 Chronic ethanol feeding promotes AOM/DSS-induced elevation of Ki67 in mouse colon. AOM/DSS-induced colonic tumorigenesis was
induced with (EF) or without (PF) 4 % ethanol feeding as described in Methods section. At the pre-cancerous stage (Day 44; 2 week after second
course of DSS colitis), colonic sections were stained for Ki67 (red) and F-actin (green) (a). Red fluorescence density in Ki67-positive cells was
measured by densitometry (b). Fluorescence values are mean ± SEM (n = 5; each n is average of 8–10 cells in each section). Asterisks indicate the
values that are significantly (p < 0.05) different from corresponding PF values. Hash tag symbols indicate the values that are significantly (p < 0.05)
different from corresponding “Control” values. Colonic sections were also co-stained for F-actin (green) and activated caspase-3 (red) (c)
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between our study and the previous studies is that we
combined AOM with DSS-induced colitis. The prevalence
of tumorigenesis in AOM/DSS model is greater than
90 %, supporting the view that inflammation plays a key
role in the promotion of colon cancer. This is consistent
with the clinical observation showing that ulcerative colitis
patients are at higher risk to develop colon cancer, and
therefore, AOM/DSS-induced tumorigenesis is a most
relevant model of human colon cancer. Ethanol-induced
promotion of AOM/DSS-induced tumorigenesis suggests
that ethanol may influence the colonic mucosal inflam-
mation rather than affecting the action of carcinogen.
These results indicate that ethanol consumption does
not cause inflammation in the colon, but it delays the
post colitis recovery from inflammation. This sustained
inflammation may play a key role in the promotion of
colonic tumorigenesis.
A number of signaling pathways, including TGFβ/Smad
signaling [29], have been implicated in the carcinogenesis
of colon. A subset of metastatic human colon cancers ex-
presses high levels of TGFβ [30]. TGFβ receptor activation
induces phosphorylation of Smad2 and Smad3 that form a
hetero multimeric complex with Smad4 leading to activa-
tion of subsequent signaling and regulation of targeted
gene expression. Recent study has suggested that Smad2/3
phosphorylation is an important event in colitis-associated
colorectal cancer and can serve as a biomarker for colitis-
associated colorectal cancer [31]. We examined the effect
of ethanol feeding on pSmad levels in colon of AOM/DSS
treated mice. Results of this study show that pSmad levels
were elevated in the colon of AOM/DSS treated mice;
pSmad levels were higher both in the non-tumor hyper-
trophic mucosa and the tumor tissue. Data also show that
ethanol feeding further elevates pSmad levels in the hyper-
trophic mucosal region. The precise role of TGFβ signal-
ing in ethanol effect is unclear. However, it is likely that
the TGFβ signaling is directly related to the sustained in-
flammation in the ethanol fed-AOM/DSS treated mice.
HIF-1α and VEGF are frequently shown to be overex-
pressed in numerous types of cancers and are known to
be important regulators of angiogenesis [32–35]. Evi-
dence suggests that HIF-1α activation regulates VEGF
gene expression, indicating a direct interaction between
these two tumor markers [33]. Results of our study show
that chronic ethanol feeding increases the level of VEGF
in the non-tumor hypertrophic colonic mucosa. VEGF
was localized predominantly in the lamina propria of
hypertrophic colonic mucosa, and connective tissue re-
gions of the tumors. Similarly, HIF-1α was also elevated
dramatically by ethanol feeding in the hypertrophic co-
lonic mucosa of AOM/DSS treated mice. HIF-1α was
high also in the tumor tissue, which appeared to be re-
duced by ethanol feeding. However, images at higher
magnification indicated that ethanol feeding increased
nuclear localization of HIF-1α in the crypts of colonic
mucosa. These results indicate that ethanol feeding en-
hances tumorigenic cell signaling during AOM/DSS-in-
duced colonic tumorigenesis.
Inflammation is a key factor in the development of
many cancers, including colorectal cancers [20, 21]. DSS
administration is well established to induce colitis [27],
and removal of DSS leads to post colitis healing with
nearly complete recovery to normalcy in 4–5 days [36]. In
the present study, ethanol was fed only during the post
colitis recovery periods. We hypothesized that ethanol de-
lays the recovery from colitis and sustains inflammation in
the colonic mucosa. To test this hypothesis we examined
colons for mucosal infiltration of neutrophils and macro-
phages at a precancerous stage, that is 2 weeks after the
second course of DSS colitis. Analysis of MPO-positive,
Gr1-positive and CD68-positive cells by immunofluores-
cence microscopy showed an absence of neutrophil and
macrophage infiltration in the colonic mucosa of mice
treated with ethanol feeding or AOM/DSS administration.
This observation suggests that ethanol by itself does not
cause colonic mucosal inflammation, and that inflamma-
tion by DSS colitis in AOM/DSS treated mice is almost
completely alleviated during the 2-week recovery period.
However, ethanol feeding delays the post colitis recovery,
and sustains inflammation even after 2 weeks of recovery.
This sustained inflammation may contribute to the mech-
anism of ethanol-induced promotion of AOM/DSS-in-
duced tumorigenesis in mouse colon.
Inflammatory cytokines such as IL-1α, IL-6 and TNFα
are elevated in colon cancer and play important role in
the mechanism of tumorigenesis [20, 21]. IL-6 and TNFα
are produced by the activated macrophages, a potential
mechanism involved in cancer development [21]. TNFα
and IL-1α were found to be elevated in MAM-induced
colon carcinogenesis [37]. Colonic mucosal inflammation
in DSS-induced colitis is associated with an increase in
the production of inflammatory cytokines and chemo-
kines. The level of inflammatory cytokines and chemo-
kines subside during post colitis healing period [36]. We
examined the colonic mucosa for the levels of mRNA for
IL-1α, IL-6 and TNFα. Ethanol feeding by itself produced
no significant effect on mRNA for IL-1α, IL-6 and TNFα.
Similarly, cytokine mRNA was unaltered in colonic mu-
cosa of AOM/DSS treated mice, which is consistent with
the lack of inflammatory cells in the colons of these mice.
Similar to its effect on neutrophil and macrophage infiltra-
tion, ethanol feeding increased mRNA levels for cytokines
in the colonic mucosa of AOM/DSS treated mice by 4–5
folds. Lack of elevated IL-6 and TNFα in the colon of
AOM/DSS treated mice indicates that the mucosa is al-
most completely recovered from colitis during 2-week re-
covery period. Elevated expression of cytokines in ethanol
fed-AOM/DSS treated mouse colon demonstrates that
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chronic ethanol feeding delays the healing process and
sustains inflammation.
Unlike in colon, in the ileum, ethanol feeding signifi-
cantly elevated IL-1α, IL-6 and TNFα mRNA levels. This
is an interesting observation, suggesting that ethanol does
induce inflammatory reactions in the ileum, but not in
colon. The mechanism and significance of this observation
is unclear at this time as no tumors were detected in the
ileum under our experimental conditions. AOM/DSS
treatment also elevated the IL-1α, IL-6 and TNFα mRNA
in the ileum, indicting that sustained inflammation exists
in the ileum of AOM/DSS treated mice. In the ileum, the
effect of ethanol on cytokine expression in AOM/DSS
treated mice was variable. Ethanol enhanced TNFα ex-
pression, whereas it decreased IL-1α expression; IL-6 ex-
pression was unaffected by ethanol.
Chemokines and chemokine receptors are known to
play a role in the mechanism of cancer metastasis [38].
While chemokines are known to play a key role in the
intestinal mucosal homeostasis and pathogenesis of in-
flammatory bowel diseases [39], chemokines such as
CXCL9/MIG and CXCL10/IP-10 are overexpressed in
colon cancer [40]. CCL5/RANTES, which is chemotactic
for macrophage and T cells, is highly expressed in both
human and mouse colon cancers, and contributes to the
inflammation and malignant progression [41]. Evidence
indicates that CCL5/RANTES helps in immune escape of
colorectal cancers. Results of our present study show that
ethanol feeding and AOM/DSS treatment significantly ele-
vated CCL5/RANTES mRNA in colon, suggesting that
both ethanol and AOM/DSS treatment increase the ex-
pression of CCL5/RANTES in colonic mucosa. A com-
bined treatment with ethanol and AOM/DSS induced a
synergistic increase in CCL5/RANTES expression, suggest-
ing that CCL5/RANTES may play a role in the mechanism
of ethanol-mediated macrophage infiltration and sustained
inflammation in AOM/DSS treated mouse colon. The
levels of mRNA for CXCL9/MIG and CXCL10/IP-10 were
unaffected by either ethanol or AOM/DSS, but they were
synergistically elevated by a combination of ethanol feeding
and AOM/DSS treatment. CXCL9/MIG and CXCL10/IP-
10 are anti-angiogenic chemokines and are likely to
suppress tumorigenesis [40]. The significance of ethanol-
induced elevation of CXCL9/MIG and CXCL10/IP-10 gene
expression is unclear at this time. However, it is likely that
these are expressed as a defense against inflammation.
Dramatic reduction in the levels of mRNA for occlu-
din, ZO-1 and Cldn3 in the colon of AOM/DSS treated
mice indicates a decline in the expression of tight junc-
tion proteins. Immunofluorescence microscopy confirms
the depletion of occludin and ZO-1 in the colon by
AOM/DSS treatment. Down regulation of cell-cell adhe-
sion proteins is an important event in the pathogenesis
of colon cancer. Interestingly, ethanol feeding worsened
the effect of AOM/DSS treatment on the expression of
tight junction proteins. Increase in the level of Ki-67 in
colonic epithelial cells by AOM/DSS treatment and its
further enhancement by ethanol feeding suggests that
ethanol may promote AOM/DSS-induced increase in
proliferative activity of colonic epithelial cells.
Conclusions
In summary, the results of this study show that chronic
ethanol feeding delays post colitis mucosal recovery lead-
ing to sustained mucosal inflammation and elevated cyto-
kine and chemokine expression. Sustained inflammation
and elevated cytokines and chemokines might play a role
in the mechanism of alcohol-mediated promotion of co-
lonic tumorigenesis. Overall, outcome of this study sug-
gests that alcohol consumption by patients with ulcerative
colitis may delay the healing and/or recurrence of the dis-
ease symptoms. Furthermore, chronic alcohol consump-
tion by patients with the history of ulcerative colitis may
elevate the risk of developing colon cancer.
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